A phase II trial of vinorelbine and intensive temozolomide for patients with recurrent or progressive brain metastases
- 7 November 2007
- journal article
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 87 (1), 85-90
- https://doi.org/10.1007/s11060-007-9491-3
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Vinorelbine combined with a protracted course of temozolomide for recurrent brain Metastases: a phase I trialJournal of Neuro-Oncology, 2006
- Oral temozolomide in heavily pre-treated brain metastases from non-small cell lung cancer: Phase II studyLung Cancer, 2005
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- Temozolomide (TMZ) combined with cisplatin (CDDP) in patients with brain metastases from solid tumors: a Hellenic Cooperative Oncology Group (HeCOG) Phase II studyJournal of Neuro-Oncology, 2005
- One week on/one week off: A novel active regimen of temozolomide for recurrent glioblastomaNeurology, 2004
- Temozolomide for the Treatment of Brain Metastases Associated With Metastatic Melanoma: A Phase II StudyJournal of Clinical Oncology, 2004
- Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trialThe Lancet, 2004
- Marked inactivation of O6-alkylguanine-DNA alkyltransferase activity with protracted temozolomide schedulesBritish Journal of Cancer, 2003
- First-Line Chemotherapy with Vinorelbine, Gemcitabine, and Carboplatin in the Treatment of Brain Metastases from Non-Small-Cell Lung Cancer: A Phase II StudyCancer Investigation, 2002
- A Randomized Trial of Surgery in the Treatment of Single Metastases to the BrainNew England Journal of Medicine, 1990